Malaria is one of the most important infectious diseases in the world. The World Health Organization estimates that there are 270 million new cases of malaria every year. Although efforts at control initially met with some success, the increasing resistance of mosquitos to insecticides and of parasites to chemotherapeutic agents makes it imperative to find new solutions to the problem. The ligand on sporozoites, the infective stage of the parasite, for hepatocytes has recently been described. Phase I of the Physician Scientist Award will focus on acquiring skills in peptide chemistry and applying them to precisely determine the primary and secondary-structure of the malaria sporozoite ligand for hepatocytes. This training will be supplemented with course work in protein chemistry as well as immunology and cell biology seminars that will be useful in Phase II of this project. Phase Il will apply the results generated during Phase I in an attempt to inhibit sporozoite invasion of hepatocytes and thereby prevent malaria infection. Efforts will focus on using a phage combinatorial library to make monoclonal antibodies to the sporozoite ligand, and on the development of new and rational peptide vaccines aiming at inhibition of sporozoite infectivity of hepatocytes. The studies proposed will contribute to the understanding of the biology of malaria parasites and to disease prophylaxis. The educational and research goals of the Physician Scientist Award will provide the physician applicant with the foundation to independently continue basic research in host-parasite interactions with an emphasis on biochemistry and immunology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Physician Scientist Award (K11)
Project #
1K11AI001175-01
Application #
3085521
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Project Start
1993-08-01
Project End
1998-07-31
Budget Start
1993-08-01
Budget End
1994-07-31
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Cougnoux, Antony; Drummond, Rebecca A; Collar, Amanda L et al. (2018) Microglia activation in Niemann-Pick disease, type C1 is amendable to therapeutic intervention. Hum Mol Genet 27:2076-2089
Sinnis, P (1998) An immunoradiometric assay for the quantification of Plasmodium sporozoite invasion of HepG2 cells. J Immunol Methods 221:17-23
Gantt, S M; Myung, J M; Briones, M R et al. (1998) Proteasome inhibitors block development of Plasmodium spp. Antimicrob Agents Chemother 42:2731-8
Sidjanski, S P; Vanderberg, J P; Sinnis, P (1997) Anopheles stephensi salivary glands bear receptors for region I of the circumsporozoite protein of Plasmodium falciparum. Mol Biochem Parasitol 90:33-41
Sinnis, P; Sim, B K (1997) Cell invasion by the vertebrate stages of Plasmodium. Trends Microbiol 5:52-8
Gantt, S M; Clavijo, P; Bai, X et al. (1997) Cell adhesion to a motif shared by the malaria circumsporozoite protein and thrombospondin is mediated by its glycosaminoglycan-binding region and not by CSVTCG. J Biol Chem 272:19205-13
Sinnis, P; Willnow, T E; Briones, M R et al. (1996) Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes. J Exp Med 184:945-54
Sinnis, P (1996) The malaria sporozoite's journey into the liver. Infect Agents Dis 5:182-9
Sinnis, P; Clavijo, P; Fenyo, D et al. (1994) Structural and functional properties of region II-plus of the malaria circumsporozoite protein. J Exp Med 180:297-306
Cerami, C; Frevert, U; Sinnis, P et al. (1994) Rapid clearance of malaria circumsporozoite protein (CS) by hepatocytes. J Exp Med 179:695-701